Bally’s Corporation (NYSE: BALY) eyes evoke plc (LSE: EVOK): why a William Hill deal would reshape UK gambling
Read More Pharma Industry News Roche’s CT-388 shows promising results in Phase I trial for obesity and Type 2 diabetes treatment Roche has announced positive outcomes from the Phase I clinical trial of CT-388, a novel dual GLP-1/GIP receptor… byPallavi MadhirajuMay 19, 2024